Pricing Log in Create free account

Lisata Therapeutics, Inc. (LSTA) vs MetaVia Inc. (MTVA)

Lisata Therapeutics, Inc. and MetaVia Inc. are both Biotechnology companies. Lisata Therapeutics, Inc. and MetaVia Inc. are of similar size ($9.6M and $9.0M). Across the 8 metrics below, Lisata Therapeutics, Inc. leads on 5 and MetaVia Inc. on 3.

Valuation

Metric LSTA MTVA Biotechnology median
P/E n/m n/m 8.50
P/S 0.62 n/m 9.71
P/B 1.17 1.10 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.09 0.64
EV/Sales 0.14 n/m 9.21
Earnings yield (159.22%) (178.24%) (33.15%)
Free cash flow yield (131.69%) (211.89%) (25.50%)

Profitability

Metric LSTA MTVA Biotechnology median
Gross margin 0.49% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (101.66%) (175.68%) (56.36%)
Return on assets (80.81%) (91.06%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LSTA MTVA Biotechnology median
Revenue growth (TTM) (24.67%) — 6.02%
EPS growth (last fiscal year) 20.42% 81.23% 30.26%
Revenue growth, 5-year CAGR (20.28%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LSTA MTVA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.69 2.06 4.72
Net debt to EBITDA 0.88 0.75 0.96

Dividend

Metric LSTA MTVA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LSTA MTVA Biotechnology median
Market cap 9.64m 9.03m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack